“…Human 4-1BB has two splice variants that produce soluble 4-1BB, which was enhanced in sera of rheumatoid arthritis, leukemia, and lymphoma patients (Furtner et al, 2005;Jung et al, 2004;Michel et al, 1998). Several members of the TNF receptor family, including TNF receptor, NGF receptor, CD27, CD30, GITR, and CD95, have been demonstrated to have soluble forms, which were generated by proteolytic cleavage and alternative splicing (Cascino et al, 1995;Cheng et al, 1994;Kohno et al, 1990;Nocentini et al, 2000;Pizzolo et al, 1990;Zupan et al, 1989). These soluble receptor forms antagonized the signaling through membrane-bound receptors (Cascino et al, 1996;Cheng et al, 1994;Kohno et al, 1990).…”